Joly Yann
Geciteerd door
Geciteerd door
International network of cancer genome projects
Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ...
Nature 464 (7291), 993-998, 2010
The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
The emergence of an ethical duty to disclose genetic research results: international perspectives
BM Knoppers, Y Joly, J Simard, F Durocher
European Journal of Human Genetics 14 (11), 1170-1178, 2006
Prepublication data sharing
Toronto International Data Release Workshop Authors
Nature 461 (7261), 168-170, 2009
Genetic discrimination and life insurance: a systematic review of the evidence
Y Joly, I Ngueng Feze, J Simard
BMC medicine 11, 1-15, 2013
A review of the key issues associated with the commercialization of biobanks
T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ...
Journal of Law and the Biosciences 1 (1), 94-110, 2014
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
M Widschwendter, A Jones, I Evans, D Reisel, J Dillner, K Sundström, ...
Nature reviews Clinical oncology 15 (5), 292-309, 2018
GA4GH: International policies and standards for data sharing across genomic research and healthcare
HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz, LJ Babb, ...
Cell genomics 1 (2), 2021
Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO)
Y Joly, ES Dove, BM Knoppers, M Bobrow, D Chalmers
PLoS computational biology 8 (7), e1002549, 2012
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
J Simard, M Dumont, AM Moisan, V Gaborieau, H Vézina, F Durocher, ...
Journal of medical genetics 44 (2), 107-121, 2007
Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers?
MB Forcier, H Gallois, S Mullan, Y Joly
Journal of Law and the Biosciences 6 (1), 317-335, 2019
Genomic cloud computing: legal and ethical points to consider
ES Dove, Y Joly, AM Tassé, BM Knoppers
European Journal of Human Genetics 23 (10), 1271-1278, 2015
Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views
G Bertier, M Hétu, Y Joly
BMC medical genomics 9, 1-12, 2016
Ethical issues of CRISPR technology and gene editing through the lens of solidarity
JJ Mulvihill, B Capps, Y Joly, T Lysaght, HAE Zwart, R Chadwick, ...
British medical bulletin 122 (1), 17-29, 2017
Open science versus commercialization: a modern research conflict?
T Caulfield, SHE Harmon, Y Joly
Genome medicine 4, 1-11, 2012
Reflections on the cost of" low-cost" whole genome sequencing: framing the health policy debate
T Caulfield, J Evans, A McGuire, C McCabe, T Bubela, R Cook-Deegan, ...
PLoS biology 11 (11), e1001699, 2013
Comparative approaches to genetic discrimination: chasing shadows?
Y Joly, IN Feze, L Song, BM Knoppers
Trends in Genetics 33 (5), 299-302, 2017
Genetic discrimination in private insurance: global perspectives
Y Joly, M Braker, M Le Huynh
New genetics and society 29 (4), 351-368, 2010
Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I)
JD Brooks, H Nabi, IL Andrulis, AC Antoniou, J Chiquette, P Després, ...
Journal of personalized medicine 11 (6), 511, 2021
Life insurance: genomic stratification and risk classification
Y Joly, H Burton, BM Knoppers, IN Feze, T Dent, N Pashayan, ...
European Journal of Human Genetics 22 (5), 575-579, 2014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20